<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>StockStream - BIIB News</title>
<link>https://stockstream.it.com/stocks/BIIB</link>
<description>Latest news and analysis for BIIB stock on StockStream.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Jul 2026 22:32:13 +0000</lastBuildDate>
<atom:link href="https://stockstream.it.com/stocks/BIIB/feed.xml" rel="self" type="application/rss+xml"/>
<ttl>15</ttl>
<item><title>BIIB Slides After Disappointing Phase 2 Alzheimer’s Trial Results</title><link>https://stockstream.it.com/news/biib-phase-2-alzheimers-trial-results</link><description>Following the Phase 2 CELIA trial of diranersen, BIIB shares fell nearly 9%. Discover the market's reaction and insights on Biogen Inc.'s future.</description><pubDate>Tue, 14 Jul 2026 19:10:59 +0000</pubDate><guid isPermaLink="true">https://stockstream.it.com/news/biib-phase-2-alzheimers-trial-results</guid><category>Healthcare</category></item>
</channel>
</rss>